Human CLA
CLA+ T cell
IL-15
IL-9
IL17A
IL17F
interleukins
psoriasis
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
06
2021
accepted:
08
10
2021
entrez:
15
11
2021
pubmed:
16
11
2021
medline:
16
11
2021
Statut:
epublish
Résumé
Psoriasis is a common inflammatory skin condition resulting from the interplay between epidermal keratinocytes and immunological cellular components. This sustained inflammation is essentially driven by pro-inflammatory cytokines with the IL-23/IL-17 axis playing a critical central role, as proved by the clinical efficacy of their blockade in patients. Among all the CD45R0
Identifiants
pubmed: 34778294
doi: 10.3389/fmed.2021.731911
pmc: PMC8585992
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
731911Informations de copyright
Copyright © 2021 de Jesús-Gil, Sans-de San Nicolàs, García-Jiménez, Ferran, Pujol and Santamaria-Babí.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Sci Transl Med. 2014 Jan 15;6(219):219ra8
pubmed: 24431112
Clin Dermatol. 2007 Nov-Dec;25(6):606-15
pubmed: 18021899
Trends Immunol. 2016 Jul;37(7):440-450
pubmed: 27178391
Arthritis Rheum. 1996 Jan;39(1):137-45
pubmed: 8546722
J Med Genet. 2002 Oct;39(10):767-8
pubmed: 12362037
Br J Dermatol. 2020 Nov;183(5):899-908
pubmed: 32012221
J Allergy Clin Immunol. 2017 Mar;139(3):923-932.e8
pubmed: 27502297
Mediators Inflamm. 2018 May 6;2018:9602362
pubmed: 29853795
J Immunol. 1993 Feb 1;150(3):1122-36
pubmed: 7678617
J Clin Invest. 2003 Nov;112(10):1571-80
pubmed: 14617758
Exp Dermatol. 2020 Jan;29(1):4-14
pubmed: 30991456
J Dermatol Sci. 2008 Aug;51(2):147-9
pubmed: 18424079
Lancet. 2021 Apr 24;397(10284):1564-1575
pubmed: 33894834
J Autoimmun. 2017 Feb;77:96-103
pubmed: 27899224
J Clin Invest. 2012 Jun;122(6):2252-6
pubmed: 22546855
J Allergy Clin Immunol. 2019 Jan;143(1):36-45
pubmed: 30414395
J Invest Dermatol. 2020 Jul;140(7):1364-1370.e1
pubmed: 31972247
Drugs Context. 2019 Apr 17;8:212570
pubmed: 31024633
Nat Med. 2012 Dec;18(12):1750-1
pubmed: 23223064
AAPS J. 2017 Jul;19(4):1218-1222
pubmed: 28534291
J Invest Dermatol. 2007 Nov;127(11):2544-51
pubmed: 17554368
Clin Immunol. 2004 Oct;113(1):38-46
pubmed: 15380528
J Allergy Clin Immunol. 2015 Feb;135(2):553-6
pubmed: 25085340
Br J Rheumatol. 1997 Jul;36(7):748-57
pubmed: 9255108
J Invest Dermatol. 1983 Jun;80 Suppl:12s-16s
pubmed: 6602189
PLoS One. 2012;7(3):e34594
pubmed: 22479649
Turk J Med Sci. 2019 Oct 24;49(5):1386-1394
pubmed: 31648514
J Invest Dermatol. 2013 Apr;133(4):999-1007
pubmed: 23190888
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):450-457
pubmed: 32662540
Ther Adv Musculoskelet Dis. 2017 Nov;9(11):277-294
pubmed: 29344110
Exp Dermatol. 2013 Jul;22(7):439-42
pubmed: 23800052
J Immunol. 2006 Feb 1;176(3):1908-15
pubmed: 16424222
J Am Acad Dermatol. 2021 Feb 3;:
pubmed: 33548305
PLoS One. 2015 Aug 07;10(8):e0134703
pubmed: 26252485
PLoS One. 2012;7(2):e30308
pubmed: 22348003
J Invest Dermatol. 2008 May;128(5):1173-81
pubmed: 18007580
Nature. 1997 Oct 30;389(6654):978-81
pubmed: 9353122
Br J Dermatol. 2009 Feb;160(2):319-24
pubmed: 19016708
Front Immunol. 2021 Mar 23;12:652613
pubmed: 33833765
Exp Dermatol. 2020 Jul;29(7):630-638
pubmed: 32476200
J Am Acad Dermatol. 2010 Mar;62(3):427-36
pubmed: 20159310
J Allergy Clin Immunol. 2016 Aug;138(2):491-499.e6
pubmed: 27056267
Lancet. 2021 Feb 6;397(10273):487-498
pubmed: 33549193
Front Immunol. 2018 Aug 02;9:1682
pubmed: 30127781
J Invest Dermatol. 2018 Mar;138(3):580-587
pubmed: 29054600
Int J Mol Sci. 2021 Feb 03;22(4):
pubmed: 33546306